Related Experiment Video
Updated: Aug 23, 2025

08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
6.5K
Multisystem inflammatory syndrome in neonates associated with SARS-CoV-2 infection, a different entity?
L B Gámez-González1,2, A S Escárcega-Juárez Ana Silvia3, D E Aguilar-Soto4
1Immunology Department, Hospital Infantil de Especialidades de Chihuahua, Chihuahua, Mexico.
Journal of Neonatal-Perinatal Medicine
|October 31, 2022
Summary
Multisystemic inflammatory syndrome in neonates (MIS-N) presents with severe multi-organ issues and Kawasaki disease-like heart problems in newborns. This condition is linked to maternal SARS-CoV-2 infection, posing diagnostic and treatment challenges.
Area of Science:
- Neonatology
- Pediatric Infectious Diseases
- Immunology
Background:
- Multisystemic inflammatory syndrome in children (MIS-C) is a novel disease linked to SARS-CoV-2.
- A similar condition, multisystemic inflammatory syndrome in neonates (MIS-N), affects newborns.
- MIS-C typically impacts children over 5 years old.
Purpose of the Study:
- To describe three cases of Mexican newborns diagnosed with MIS-N.
- To highlight the multiorgan compromise and Kawasaki disease (KD)-like cardiac manifestations in these neonates.
- To discuss the diagnostic and therapeutic challenges associated with MIS-N.
Main Methods:
- Case series reporting on three Mexican newborns.
- Clinical presentation, laboratory findings (including anti-SARS-CoV-2 IgG), and cardiac features were analyzed.
- Review of current literature on MIS-N and KD.
Main Results:
- Three newborns presented with MIS-N, multiorgan compromise, and positive anti-SARS-CoV-2 IgG.
- All three infants developed cardiac abnormalities resembling Kawasaki disease.
- The cases underscore the potential impact of SARS-CoV-2 on neonatal health.
Conclusions:
- MIS-N is a distinct entity in neonates, presenting with severe systemic inflammation and cardiac involvement.
- Early diagnosis and management are crucial, though challenging due to overlapping symptoms with other neonatal conditions.
- Further research is needed to understand the pathophysiology and optimize treatment strategies for MIS-N.
Related Concept Videos
Pneumonia II: Pathophysiology
429
The pathophysiology of pneumonia involves the following steps:
429
Acute Respiratory Failure-II
319
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
319

